Venous Ablation Therapy: Indications and Outcomes

https://doi.org/10.1016/j.pcad.2011.04.006Get rights and content

Abstract

Venous disease has long been recognized as a progressive, debilitating, and recurrent problem. Until recently, venous insufficiency was often undertreated due to a lack of therapeutic modalities. During the past decade, an explosion in the treatment options has occurred. Endovenous ablation therapy has nearly replaced the conventional surgical treatments for patients with superficial venous insufficiency. Dramatic changes in therapy are also available for deep venous thrombosis but are not the subject of this review. These newer techniques are much less invasive and consequently have reduced risks of wound complications or bleeding. In addition, they can be performed easily in the office setting with local anesthesia. Higher-risk patients can now be considered for these less invasive treatments to reduce their ambulatory venous hypertension. With the lower procedural risks and the dramatically shortened recovery times, earlier intervention can be entertained. This helps prevent the development of venous stasis ulceration and other sequelae of progressive venous insufficiency.

Introduction

Although most concentration has been on the initial management of acute venous thromboembolism, many patients suffer from the long-term ravages of chronic venous disease. This spectrum of chronic venous insufficiency includes limb swelling, skin discoloration, skin ulcerations, and venous varicosities. Venous varicosities often cause cosmetically unappealing findings; however, venous valvular incompetence may result in venous stasis ulcerations that are refractory to therapy without management of the venous varicosities. Endovenous ablation of venous varicosities has largely replaced primary surgical venous ligation and stripping as the primary therapeutic modality. This article will highlight the advances in endovenous management of venous varicosities.

Section snippets

History

Evaluation of every patient should start with a complete medical history including a risk assessment for thrombosis, consisting of the patient's and family's history of thrombotic events (including superficial phlebitis), medications, tobacco use, and history of obesity. Presence and severity of symptoms should be assessed. Suspicion of proximal venous obstruction should be higher in patients with severe edema or venous ambulatory claudication (bursting pain with ambulation.) Premenopausal

Indications for ablation

Symptomatic patients who have varicose veins, edema, skin changes, or ulceration (CEAP 2-6) with axial reflux in one or more superficial truncal veins are considered candidates for therapy. Initially, a patient should be treated conservatively, and intervention can be considered when there are persistent symptoms or signs of progressive chronic venous disease (CVD).

One might consider saphenous vein preservation in patients who have varicosities with less severe disease (C2), a refluxing GSV

Outcomes

Overall results after endovenous ablation treatments are positive. There is high patient satisfaction, minimal recovery time, and only minor risks. We have established that superficial venous insufficiency is associated with a progression of signs and symptoms; and when the ambulatory venous hypertension is not corrected, this leads to progressive skin changes and ulceration. In addition to helping improve the quality of life (QOL), there is a benefit in preventing progression of venous disease

Laser vs high ligation and stripping

There have been 7 randomized trials to date comparing EVL with conventional high ligation and stripping (HLS) of the GSV. Most conclude that there is equal safety and mid-term efficacy between the 2 treatments. However, some differences are noted between HLS and EVL in the early postoperative period and short-term follow-up. Darwood et al11 randomized patients to EVL or HLS, both treatments that were similar in elimination of reflux and QOL. This study reported return to normal activity in 2

Radiofrequency results

Although RF has been used longer than the other technologies, the first-generation RF catheter had technological issues that made it somewhat less effective. Retractable electrodes often developed thrombus with the slower pull back speed, despite a heparin drip running through the catheter. Contact with the vein wall was not always sufficient, or pull back was performed too rapidly. Occasionally, these factors resulted in less energy delivery to the vein wall and insufficient obliteration of

Radiofrequency vs HLS

There have been several randomized trials comparing RF ablation with HLS, but all are comparisons to the first-generation RF device. The EVOLVeS20 study was a multicenter, prospective, randomized trial involving 85 patients with a 2-year follow-up. They showed significant improvement in postoperative pain, shorter recovery time, fewer adverse events, and superior QOL scores immediately after the RF ablation vs the HLS group. At 2 years follow-up, there were no differences noted in clinical

Radiofrequency vs laser

Gale et al21 performed a randomized trial between 810 nm EVL and the older-generation (ClosurePLUS, VNUS Medical, Calif) RF device. This showed a significantly higher incidence of bruising, less improvement in VCSS, and greater discomfort after EVL, but these differences did not persist after 1 month. They also reported that there was a higher incidence of recanalization in the RF group vs EVL (22.9% vs 4.3%, P = .02) at 1 year. This study did not include the newer-generation RF catheter.

Van

Conclusions

Both hemodynamic and clinical improvement is observed in patients after superficial ablation of refluxing truncal veins. Many treatment modalities exist including surgical stripping, saphenous vein preservation, endovenous thermal ablation (with RF or laser), and endovenous chemical ablation. Indications for treatment include patients who have axial vein reflux and those who have signs or symptoms of progressive venous disease despite conservative measures. Refluxing veins must be mapped

Statement of Conflict of Interest

The author declares that there is no conflict of interest.

References (24)

Cited by (8)

  • What's new: Management of venous leg ulcers Treating venous leg ulcers

    2016, Journal of the American Academy of Dermatology
    Citation Excerpt :

    In comparison to surgical procedures, EVA procedures have equivalent safety and efficacy to surgical ligation/stripping of saphenous veins.91 In addition to patients with ulcers, symptomatic patients with edema, varicose veins, and skin changes are candidates for endovenous ablation.92,93 Understanding the venous anatomy is important for those performing vascular intervention; anatomic differences in disease may cause different clinical manifestations and require specific intervention(s).

  • Wound Healing Update

    2012, Seminars in Cutaneous Medicine and Surgery
View all citing articles on Scopus

Statement of Conflict of Interest: see page 69.

View full text